| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,263 |
5,325 |
$120K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,113 |
992 |
$106K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
752 |
697 |
$53K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
282 |
282 |
$53K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,952 |
9,469 |
$33K |
| 92551 |
|
1,558 |
1,546 |
$10K |
| G9920 |
Screening performed and negative |
435 |
433 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
240 |
240 |
$9K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
246 |
244 |
$7K |
| 92552 |
|
750 |
749 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
661 |
423 |
$5K |
| 90658 |
|
833 |
824 |
$5K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
322 |
322 |
$4K |
| 99000 |
|
1,146 |
1,140 |
$4K |
| 88150 |
|
351 |
347 |
$3K |
| 85018 |
|
2,460 |
2,390 |
$2K |
| 86580 |
|
895 |
887 |
$2K |
| 81000 |
|
2,229 |
2,193 |
$2K |
| 99173 |
|
1,381 |
1,373 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46 |
45 |
$2K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
29 |
28 |
$1K |
| 90620 |
|
371 |
332 |
$950.16 |
| 81003 |
|
386 |
384 |
$798.99 |
| 83026 |
|
322 |
322 |
$790.44 |
| 90686 |
|
489 |
487 |
$639.19 |
| 90649 |
|
168 |
153 |
$540.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
15 |
15 |
$428.92 |
| 90715 |
|
108 |
102 |
$424.50 |
| 81025 |
|
115 |
112 |
$235.92 |
| 90734 |
|
44 |
43 |
$172.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
354 |
351 |
$154.25 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
41 |
40 |
$26.71 |
| 90461 |
|
302 |
201 |
$24.24 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$23.46 |
| 36415 |
Collection of venous blood by venipuncture |
3,024 |
2,909 |
$16.50 |
| 36410 |
|
233 |
232 |
$11.14 |
| 3008F |
|
12,025 |
9,580 |
$7.50 |
| 1160F |
|
4,468 |
3,699 |
$6.00 |
| 1159F |
|
4,491 |
3,719 |
$6.00 |
| 3078F |
|
9,360 |
7,703 |
$5.10 |
| 3074F |
|
8,984 |
7,427 |
$4.20 |
| 3075F |
|
1,143 |
1,070 |
$1.20 |
| 87081 |
|
14 |
14 |
$1.00 |
| 4037F |
|
684 |
680 |
$0.60 |
| 3079F |
|
1,482 |
1,360 |
$0.60 |
| 3077F |
|
1,368 |
1,200 |
$0.30 |
| 3044F |
|
91 |
86 |
$0.00 |
| 3080F |
|
415 |
388 |
$0.00 |
| 81001 |
|
441 |
427 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
16 |
16 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
16 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
56 |
56 |
$0.00 |
| 97802 |
|
38 |
38 |
$0.00 |
| 81005 |
|
83 |
82 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
26 |
26 |
$0.00 |
| 3725F |
|
85 |
83 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
160 |
156 |
$0.00 |
| 92081 |
|
120 |
120 |
$0.00 |
| 81002 |
|
105 |
105 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
134 |
132 |
$0.00 |
| 86703 |
|
27 |
27 |
$0.00 |
| 91300 |
|
13 |
13 |
$0.00 |
| 80061 |
Lipid panel |
14 |
14 |
$0.00 |